Wednesday, October 15, 2014

FDA: Chantix warnings about suicide thoughts and other side effects should stay

Earlier this month, I reported that Pfizer was seeking to have the warnings on possible suicidal thoughts removed from its drug Chantix even though the drug has been reported to be linked to more suicidal thoughts cases than any other drug.

Now, as the debate over the need for psychiatric warnings for Chantix continues, FDA staff reviewers  have indicated that the drug should continue to carry a black box warning to alert users about the risk of suicidal thoughts, violent behavior and other unusual actions while taking the medications.  Go to AboutLawsuits for the full story.

UPDATE 10/17/14:  AboutLawsuits has a follow up here.

No comments: